Stockholm 3 Blood Test For Prostate Cancer to Reduce Unnecessary Biopsies

Stockholm3 blood test

From article written December 14, 2026 at news.feinberg.northwestern.edu – Blood Test May Reduce Unnecessary Prostate Cancer Biopsies – according to a recent multi-center trial published in the Journal of Clinical Oncology.   Prostate cancer remains a significant health concern for men, particularly those in high-risk groups. Recent developments in blood testing technology may revolutionize the screening process, potentially reducing …

Read more

Prostate Health Index: A Key Tool for Early Cancer Detection

Prostate Health Index, PHI

The Prostate Health Index (PHI) is revolutionizing prostate cancer detection. This innovative blood test combines three biomarkers to provide a more accurate assessment of prostate cancer risk. The PHI test has shown superior performance in identifying clinically significant prostate cancer compared to traditional prostate-specific antigen (PSA) screening alone. PHI addresses a critical need in prostate …

Read more